Converting the World’s Most
Meaningful Medications

into Liquid Oral Suspensions

Reagenzglas wird von zwei Händen in Handschuhen gehalten

ABOUT US

At Aspargo Labs, we are committed to transforming medication delivery.

Using our proprietary technology, we convert medications into oral suspensions – providing greater flexibility in dosing and ease of use and improving convenience for our patients.

We have also pioneered a state-of-the-art dispenser that improves medication administration and sets new standards for patient adherence in the healthcare industry.

Aspargo

A groundbreaking approach to reformulating liquid medicines

At Aspargo Labs, pharmaceutical and biotech professionals work closely together, leveraging decades of experience in developing and commercialising innovative therapeutics, preparing and submitting regulatory applications to the FDA, EMA and MHRA and securing drug approvals worldwide.

Michael Demurjian, Chairman and CEO
Michael Demurjian
Chairman and CEO
Steven Kaplan, MD, Chief Medical Advisor
Steven Kaplan, MD
Chief Medical Advisor
Mario Guralnik, Ph.D - Chief Regulatory Officer
Mario Guralnik, Ph.D
Chief Regulatory Officer
Andrew Chamlin - Chief Marketing Officer
Andrew Chamlin
Chief Marketing Officer
Harold D. Tamayo - Chief Financial Officer
Harold D. Tamayo
Chief Financial Officer
Jamel Benkreira - General Manager, UK & Ireland
Jamel Benkreira
General Manager, UK & Ireland
Medicals walking

TRANSFORMING MEDICATION DELIVERY

Aspargo Labs is at the forefront of medication delivery with its groundbreaking oral spray technology, converting medicines into convenient, liquid suspensions. Its innovative technique not only enhances patient convenience, but also improves treatment delivery while avoiding common tablet-related challenges.

PATIENT ADHERENCE WITH HIGH-TECH DISPENSERS

Aspargo Labs is committed to pushing the boundaries of research and raising science to new heights. It leads the way with its high-tech delivery devices and interchangeable medication cartridges, which will eventually integrate with a user-friendly app. These groundbreaking devices enable precise dosing and encourage adherence, while providing realtime patient data to healthcare professionals, caregivers and support staff.

spheres

STRATEGIC PARTNERS

Collaboration with our valued partners builds credibility and trust, raising awareness of medication issues and adherence.

IPG Health, Weber Shandwick, Inizio evoke, Profarma Distrtibuicao, Saptalis Pharmaceuticals LLC, Russo Partners / LLC, Synergy Research+

ASP-008-002 | May 2025